Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice.
- 1 October 1996
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 93 (20) , 11008-11013
- https://doi.org/10.1073/pnas.93.20.11008
Abstract
Interleukin 1 receptor antagonist (IL-1ra) is a cytokine whose only known action is competitive inhibition of the binding of interleukin 1 (IL-1) to its receptor. To investigate the physiological roles of endogenously produced IL-1ra, we generated mice that either lack IL-1ra or overproduce it under control of the endogenous promoter. Mice lacking IL-1ra have decreased body mass compared with wild-type controls. They are more susceptible than controls to lethal endotoxemia but are less susceptible to infection with Listeria monocytogenes. Conversely, IL-1ra overproducers are protected from the lethal effects of endotoxin but are more susceptible to listeriosis. Serum levels of IL-1 following an endotoxin challenge are decreased in IL-1ra nulls and increased in IL-1ra overproducers in comparison to controls. These data demonstrate critical roles for endogenously produced IL-1ra in growth, responses to infection and inflammation, and regulation of cytokine expression.Keywords
This publication has 29 references indexed in Scilit:
- Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist.The Journal of Experimental Medicine, 1995
- Resistance to fever induction and impaired acute-phase response in interleukin-1β-deficient miceImmunity, 1995
- INTERLEUKIN-1 AND INTERLEUKIN-1 ANTAGONISM IN SEPSIS, SYSTEMIC INFLAMMATORY RESPONSE SYNDROME, AND SEPTIC SHOCKShock, 1995
- Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shockCell, 1995
- Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis.Journal of Clinical Investigation, 1994
- The mouse interleukin 1 receptor antagonist protein: gene structure and regulation in vitroCytokine, 1994
- Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia.Journal of Clinical Investigation, 1992
- Interleukin-1 receptor antagonist reduces mortality from endotoxin shockNature, 1990
- Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitorNature, 1990
- Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice.The Journal of Experimental Medicine, 1988